Prognosis
Biden Advisers Met Warp Speed Drugmakers Before Election
- New administration seen seeking continuity, not big changes
- Vaccines and new therapies expected to get U.S. clearance soon
This article is for subscribers only.
President-elect Joe Biden’s health-care advisers have held talks with pharmaceutical-industry executives in which they discussed Operation Warp Speed, the U.S. development program for coronavirus vaccines and treatments, according to people familiar with the matter.
Biden advisers met with companies that have Covid-19 vaccines or therapies in late-stage clinical trials in September and October, the people said. The purpose was to gather information about the development, manufacturing and distribution of shots to ward off the novel coronavirus and therapies to treat the sick.